$0.4200
At close: Mar 28, 5:00 PM EST
$0.9590
0.54128.33%
After Hours: Oct 20, 4:00 PM EST
Avenue Therapeutics Inc Earnings Estimates
ATXIOTCID
Avenue Therapeutics Earnings Estimates, EPS & Revenue | OTC:ATXI
Avenue Therapeutics (ATXI) is scheduled to report Q1 earnings on May 14, 2026.
Avenue Therapeutics has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Avenue Therapeutics has averaged an EPS surprise of 2.04% and a revenue surprise of 0.00%.
Earnings Date
Mar 30
EPS
$-0.220
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.40M
Avenue Therapeutics Earnings History
Analyze the earnings history of Avenue Therapeutics using advanced sorting and filters.
Loading calendar...
Avenue Therapeutics (ATXI) Earnings Per Share
The chart below shows Avenue Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Avenue Therapeutics (ATXI) Revenue
The chart below shows Avenue Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Avenue Therapeutics (OTCID:ATXI) reporting earnings?
Avenue Therapeutics (ATXI) is scheduled to report earnings on May 14, 2026. The last reported earnings were for reported on March 30, 2026 for Q4.
What were the latest earnings per share (EPS) for Avenue Therapeutics (OTCID:ATXI)?
The Actual EPS was $-0.22, which missed the estimate of $0.00.
What were Avenue Therapeutics’s (OTCID:ATXI) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
